Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Tammaro, Alessandra ^a   Stroo, Ingrid ^a   Rampanelli, Elena ^a   Blank, Froilan ^a   Butter, Loes M ^a   Claessen, Nike ^a   Takai, Toshiyuki ^b   Colonna, Marco ^c   Leemans, Jaklien C ^a   Florquin, Sandrine ^a,d   Dessing, Mark C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b TOHOKU UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CYTOKINE; KERATINOCYTE DERIVED CYTOKINE; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; KIDNEY FIBROSIS; MACROPHAGE; MOUSE; NEPHRITIS; NONHUMAN; URETER OBSTRUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DISEASE PROGRESSION; FEMALE; HUMANS; HYDRONEPHROSIS; INFLAMMATION; KIDNEY; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84892733819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082498     Document Type: Article

References (50)

1. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. The Journal of clinical investigation 117: 524-529.
2. Chevalier RL, Forbes MS, Thornhill BA (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney international 75: 1145-1152.
3. Boor P, Ostendorf T, Floege J (2010) Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature reviews 6: 643-656.
4. Chevalier RL, Thornhill BA, Forbes MS, Kiley SC (2010) Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatric nephrology. Pediatr Nephrol 4: 687-697.
5. Zeisberg M, Neilson EG (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834.
6. Anders HJ, Banas B, Schlondorff D (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 15: 854-867.
7. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, et al. (2010) The role of Toll-like receptors in renal diseases. Nature reviews 6: 224-235.
8. Colonna M (2003) TREMs in the immune system and beyond. Nat Rev Immunol 3: 445-453.
9. Sharif O, Knapp S (2008) From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213: 701-713.
10. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, et al. (2007) Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111: 36-44.
11. Leemans JC, Butter LM, Pulskens WP, Teske GJ, Claessen N, et al. (2009) The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 4: e5704.
12. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, et al. (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21: 1299-1308.
13. Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, et al . (2012) The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer research 72: 3977-3986.
14. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, et al. (2010) Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Disease models & mechanisms 3: 92-103.
15. Correa-Costa M, Braga TT, Semedo P, Hayashida CY, Bechara LR, et al. (2011) Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One 6: e29004.
16. Braga TT, Correa-Costa M, Guise YF, Castoldi A, De Oliveira CD, et al. (2012) MyD88 Signaling Pathway is Involved in Renal Fibrosis by favoring a TH2 Immune Response and Activating Alternative M2 Macrophages. Molecular medicine 18:1231-9.
17. Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, et al. (2006) Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 17: 2622-2632.
18. Klesney-Tait J, Keck K, Li X, Gilfillan S, Otero K, et al. (2012) Transepithelial migration of neutrophils into the lung requires TREM-1. The Journal of clinical investigation 123(1):138-49.
19. Kaifu T, Nakahara J, Inui M, Mishima K, Momiyama T, et al. (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. The Journal of clinical investigation 111: 323-332.
20. Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I, et al. (2004) CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 15: 674-686.
21. Rouschop KM, Claessen N, Pals ST, Weening JJ, Florquin S (2006) CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis. J Am Soc Nephrol 17: 746-753.
22. Stokman G, Leemans JC, Stroo I, Hoedemaeker I, Claessen N, et al. (2008) Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis. Nephrol Dial Transplant 23: 483-491.
23. Moorman AF, Houweling AC, de Boer PA, Christoffels VM (2001) Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. J Histochem Cytochem 49: 1-8.
24. Arts RJ, Joosten LA, Dinarello CA, Kullberg BJ, van der Meer JW, et al. (2011) TREM-1 interaction with the LPS/TLR4 receptor complex. European cytokine network 22: 11-14.
25. Lanier LL (2009) DAP10- and DAP12-associated receptors in innate immunity. Immunological reviews 227: 150-160.
26. Colonna M, Facchetti F (2003) TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. The Journal of infectious diseases 187 Suppl 2: S397-S401.
27. Chen LC, Laskin JD, Gordon MK, Laskin DL (2008) Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol 84: 145-155.
28. Matesanz-Isabel J, Sintes J, Llinas L, de Salort J, Lazaro A, et al. (2011) New B-cell CD molecules. Immunol Lett 134: 104-112.
29. Rigo I, McMahon L, Dhawan P, Christakos S, Yim S, et al. (2012) Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)(2) vitamin D(3). Innate immunity 18: 250-257.
30. Hyder LA, Gonzalez J, Harden JL, Johnson-Huang LM, Zaba LC, et al. (2013) TREM-1 as a potential therapeutic target in psoriasis. J Invest Dermatol 133: 1742-1751.
31. Ford JW, McVicar DW (2009) TREM and TREM-like receptors in inflammation and disease. Current opinion in immunology 21: 38-46.
32. Gibot S, Massin F, Alauzet C, Montemont C, Lozniewski A, et al. (2008) Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Critical care medicine 36: 504-510.
33. Gibot S, Massin F, Alauzet C, Derive M, Montemont C, et al. (2009) Effects of the Trem-1 Pathway Modulation During Hemorrhagic Shock in Rats. Shock 32(6):633-7.
34. Kamei K, Yasuda T, Ueda T, Qiang F, Takeyama Y, et al. (2010) Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. Journal of hepato-biliary-pancreatic sciences 17: 305-312.
35. Lech M, Susanti HE, Rommele C, Grobmayr R, Gunthner R, et al. (2012) Quantitative expression of C-type lectin receptors in humans and mice. International journal of molecular sciences 13: 10113-10131.
36. Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991-4995.
37. Ramaiah SK, Gunthner R, Lech M, Anders HJ (2013) Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis. International journal of molecular sciences 14: 13213-13230.
38. Koth LL, Cambier CJ, Ellwanger A, Solon M, Hou L, et al. (2010) DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2. J Immunol 184: 6522-6528.
39. Cetin S, Ford HR, Sysko LR, Agarwal C, Wang J, et al. (2004) Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions. The Journal of biological chemistry 279: 24592-24600.
40. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, et al. (2005) Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Investigative ophthalmology & visual science 46: 114-120.
41. Sawa Y, Ueki T, Hata M, Iwasawa K, Tsuruga E, et al. (2008) LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J Histochem Cytochem 56: 97-109.
42. Ornatowska M, Azim AC, Wang X, Christman JW, Xiao L, et al . (2007) Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 293: L1377-L1384.
43. Yamanishi Y, Takahashi M, Izawa K, Isobe M, Ito S, et al. (2012) A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J Immunol 189: 1773-1779.
44. Banerjee A, Stevenaert F, Pande K, Haghjoo E, Antonenko S, et al. (2010) Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumonia. Infection and immunity 78: 1353-1363.
45. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, et al. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672-676.
46. Cheung R, Shen F, Phillips JH, McGeachy MJ, Cua DJ, et al. (2010) Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice. The Journal of clinical investigation 121: 4446-4461.
47. Yotsumoto K, Okoshi Y, Shibuya K, Yamazaki S, Tahara-Hanaoka S, et al. (2003) Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. The Journal of experimental medicine 198: 223-233.
48. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, et al . (2006) Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107: 3600-3608.
49. Takamiya R, Ohtsubo K, Takamatsu S, Taniguchi N, Angata T (2013) The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-beta secretion from monocytes/macrophages through the DAP12-Syk pathway. Glycobiology 23: 178-187.
50. Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, et al. (2010) TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. The Journal of experimental medicine 207: 1501-1511.